Estimates of neutron relative biological effectiveness derived from the Japanese atomic bomb survivors

International Journal of Radiation Biology

Volumn 72, Issue 6, 1997, Pages 715-726

  Little, M P ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ATOMIC BOMB SURVIVOR; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CONTROLLED STUDY; FEMALE; GAMMA RADIATION; HUMAN; JAPAN; LEUKEMIA; MAJOR CLINICAL STUDY; MALE; NEUTRON DOSIMETRY; PRIORITY JOURNAL; RADIATION EXPOSURE; RELATIVE BIOLOGIC EFFECTIVENESS; SOLID TUMOR;

HUMANS; JAPAN; NEUTRONS; NUCLEAR WARFARE; RADIATION DOSAGE; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK;

EID: 0031474139     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530097142870     Document Type: Article

References (37)

1. BRENNER, D. J., 1991, Significance of neutrons from the atomic bomb at Hiroshima for revised radiation risk estimates. Health Physics, 60, 439-442.
2. BRENNER, D. J., 1996, Direct biological evidence for a significant neutron dose to survivors of the Hiroshima atomic bomb. Radiation Research, 145, 501-507.
3. BRENNER, D. J. and SACHS, R. K., 1994, Chromosomal 'fingerprints' of prior exposure to densely ionizing radiation. Radiation Research, 140, 134-142.
4. BRENNER, D. J. and SACHS, R. K., 1996, Comments on 'Comment on the ratio of chromosome-type dicentric interchanges to centric rings for track-clustered compared with random breaks' by Savage and Papworth (Radiat. Res. 146, 236-240, 1996) (letter). Radiation Research, 146, 241-242.
5. DOBSON, R. L., STRAUME, T., CARRANO, A. V., MINKLER, J. L., DEAVEN, L. L., LITTLEFIELD, L. G. and AWA, A. A., 1991, Biological effectiveness of neutrons from Hiroshima bomb replica: results of a collaborative cytogenetic study. Radiation Research, 128, 143-149.
6. GRIMWOOD, P. and CHARLES, M. W., 1994, The possible repercussions of further revisions in the Japanese atomic bomb dosimetry. In Proceedings of the 17th IRPA Regional Congress, edited by W. Nimmo-Scott and D. J. Golding (Ashford: Nuclear Technology Publishing), pp. 213-216.
7. Internation Commission on Radiological Protection (ICRP), 1991, 1990 Recommendations of the International Commission on Radiological Protection. Annals of the ICRP, 21 (1 3) (Oxford: Pergamon).
8. International Commission on Radiation Units and Measurements (ICRU), 1986, The Quality Factor in Radiation Protection. ICRU Report 40 (Bethesda, MD: ICRU).
9. LEENHOUTS, H. P. and CHADWICK, K. H., 1994, A two-mutation model of radiation carcinogenesis: application to lung tumours in rodents and implications for risk evaluation. Journal of Radiological Protection, 14, 115-130.
10. LITTLE, M. P. and CHARLES, M. W., 1997, The risk of non-melanoma skin cancer incidence in the Japanese atomic bomb survivors. International Journal of Radiation Biology, 71, 589-602.
11. LITTLE, M. P. and MUIRHEAD, C. R., 1996, Evidence for curvilinearity in the cancer incidence dose-response in the Japanese atomic bomb survivors. International Journal of Radiation Biology, 70, 83-94.
12. LITTLE, M. P., DE VATHAIRE, F., CHARLES, M. W., HAWKINS, M. M. and MUIRHEAD, C. R., 1997a, Variations with time and age in the relative risks of solid cancer incidence after radiation exposure. Journal of Radiological Protection, 17, 159-177.
13. LITTLE, M. P., MUIRHEAD, C. R. and CHARLES, M. W., 1997b, Describing time and age variations in the risk of radiation-induced solid tumour incidence in the Japanese atomic bomb survivors using generalised relative and absolute risk models. Submitted to Statistics in Medicine.
14. MCCULLAGH, P. and NELDER, J. A., 1989, Generalised Linear Models, 2nd edn (London: Chapman & Hall).
15. MILTON, R. C. and SHOHOJI, T., 1968, Tentative 1965 Radiation Dose Estimates for Atomic Bomb Survivors, Hiroshima and Nagasaki. ABCC Technical Report TR 1 68 (Hiroshima: Atomic Bomb Casualty Commission).
16. NAGATOMO, T., HOSHI, M. and ICHIKAWA, Y., 1995, Thermoluminescence dosimetry of the Hiroshima atomic-bomb gamma rays between 1.59 km and 1.63 km from the hypocenter. Health Physics, 69, 556-559.
17. National Council on Radiation Protection and Measurements (NCRP), 1990, The Relative Biological Effectiveness of Radiations of Different Quality. NCRP Report 104 (Bethesda, MD: NCRP).
18. PRESTON, D. L. and PIERCE, D. A., 1987, The Effect of Changes in Dosimetry on Cancer Mortality Risk Estimates in the Atomic Bomb Survivors. RERF Technical Report TR 9 87 (Hiroshima: Radiation Effects Research Foundation).
19. PRESTON, D. L. and SPOSTO, R., 1991, RBE and Dose-Response Functions. RERF Update, 3 (3) (Hiroshima: Radiation Effects Research Foundation), pp. 3-4.
20. PRESTON, D. L., KUSUMI, S., TOMONAGA, M., IZUMI, S., RON, E., KURAMOTO, A., KAMADA, N., DOHY, H., MATSUO, T., NONAKA, H., THOMPSON, D. E., SODA, M. and MABUCHI, K., 1994, Cancer incidence in atomic bomb survivors. Part III: leukemia, lymphoma and multiple myeloma, 1950-1987. Radiation Research, 137, S68-S97.
21. PRESTON, D. L., MABUCHI, K., PIERCE, D. A. and SHIMIZU, Y., 1997, Mortality among atomic-bomb survivors, 1950-1990. In Proceeding of the Thirty-Second Annual Meeting of the National Council on Radiation Protection and Measurements. Proceedings No. 18. Implications of New Data on Radiation Cancer Risk, edited by J.D. Boice (Bethesda, MD: NCRP), pp. 31-39.
22. PIERCE, D. A., SHIMIZU, Y., PRESTON, D. L., VAETH, M. and MABUCHI, K., 1996, Studies of the mortality of atomic bomb survivors. Report 12, part I. Cancer: 1950-1990. Radiation Research, 146, 1-27.
23. ROESCH, W. C. (ed.), 1987a, US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Volume 1 (Hiroshima: Radiation Effects Research Foundation).
24. ROESCH, W. C. (ed.), 1987b, US-Japan Joint Reassessment of Atomic Bomb Radiation Dosimetry in Hiroshima and Nagasaki. Volume 2 (Hiroshima: Radiation Effects Research Foundation).
25. ROSSI, H. H. and MAYS, C. W., 1978, Leukemia risk from neutrons. Health Physics, 34, 353-360.
26. ROSSI, H. H. and ZAIDER, M., 1990, Contributions of neutrons to the biological effects in Hiroshima. Health Physics, 58, 645-647.
27. ROSSI, H. H. and ZAIDER, M., 1991, Neutron RBE for A-bomb Survivors. RERF Update, 3 (1) (Hiroshima: Radiation Effects Research Foundation), pp. 3-4.
28. SAVAGE, J. R. K. and PAPWORTH, D. G., 1996, Comment on the ratio of chromosome-type dicentric interchanges to centric rings for track-clustered compared with random breaks. Radiation Research, 146, 236-240.
29. SHIMIZU, Y., KATO, H. and SCHULL, W. J., 1990, Studies of the mortality of A-bomb survivors. 9. Mortality, 1950-1985: Part 2. Cancer mortality based on the recently revised doses (DS86). Radiation Research, 121, 120-141.
30. 60Co activities induced by neutrons from the Hiroshima atomic bomb. Health Physics, 65, 272-282.
31. STRAM, D. O., SPOSTO, R., PRESTON, D., ABRAHAMSON, S., HONDA, T. and AWA, A. A., 1993, Stable chromosome aberrations among A-bomb survivors: an update. Radiation Research, 136, 29-36.
32. R. Health Physics, 69, 954-956.
33. STRAUME, T., 1996, Risk implications of the neutron discrepancy in the Hiroshima DS86 dosimetry system. Radiation Protection Dosimetry, 67, 9-12.
34. STRAUME, T., EGBERT, S. D., WOOLSON, W. A., FINKEL, R. C., KUBIK, P. W., GOVE, H. E., SHARMA, P. and HOSHI, M., 1992, Neutron discrepancies in the DS86 Hiroshima dosimetry system. Health Physics, 63, 421-426.
35. STRAUME, T., HARRIS, L. J., MARCHETTI, A. A. and EGBERT, S. D., 1994, Neutrons confirmed in Nagasaki and at the Army Pulsed Radiation Facility: implications for Hiroshima. Radiation Research, 138, 193-200.
36. STRAUME, T., MARCHETTI, A. A. and MCANINCH, J. E., 1996, New analytical capability may provide solution to the neutron dosimetry problem in Hiroshima. Radiation Protection Dosimetry, 67, 5-8.
37. THOMPSON, D. E., MABUCHI, K., RON, E., SODA, M., TOKUNAGA, M., OCHIKUBO, S., SUGIMOTO, S., IKEDA, T., TERASAKI, M., IZUMI, S. and PRESTON, D. L., 1994, Cancer incidence in atomic bomb survivors. Part II: solid tumors, 1958-1987. Radiation Research, 137, S17-S67.